About
Mr. Klein is currently Managing Director of Gauss Capital Advisors, LLC, a financial consulting and investment advisory firm focused on biopharmaceuticals, which he founded in March 1998. Mr. Klein currently serves on the board of directors of the public biotechnology company Isis Pharmaceuticals, Inc. as well as the Board of Directors of the Prospector Funds, Inc., an SEC registered investment company that manages two no-load mutual funds. He has previously served on the boards and Audit Committees of BioMarin Pharmaceutical, Inc.; Clinical Data, Inc.; Genaissance Pharmaceuticals, Inc.; Guilford Pharmaceuticals, Inc.; NPS Pharmaceuticals, Inc.; OSI Pharmaceuticals, Inc.; PDL BioPharma, Inc.; Savient Pharmaceuticals, Inc.; and Synbiotics, Inc. Mr. Klein also serves on the boards of private and non-profit entities. From 1989 to 1998, Mr. Klein was a health care investment analyst at T. Rowe Price Associates, Inc., where he was the founding portfolio manager of the T. Rowe Price Health
Position in the VCSift Database
- • 1,801 investors hold the Managing Director role in VCSift. Skip Klein is one of them.
- • 4 investors are based in Stevenson, Maryland, United States.
Data sourced from 410,343 investor profiles. Updated September 2026.
Investment Focus
- Location
- Stevenson, US
Contact Information
Find more investors like Skip
Search Investors